Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| ID | DOID:3495 |
| Name | extrahepatic bile duct adenocarcinoma |
| Definition | An extrahepatic bile duct carcinoma that derives_from epithelial cells of glandular origin. |
| Source | DiseaseOntology.org |
| Alt Ids | |
| Xrefs |
|
| Path | disease disease of cellular proliferation cancer organ system cancer gastrointestinal system cancer hepatobiliary system cancer biliary tract cancer bile duct cancer bile duct carcinoma bile duct adenocarcinoma cholangiocarcinoma extrahepatic bile duct carcinoma extrahepatic bile duct adenocarcinoma |
| Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07433673 | Phase II | Cemiplimab + Cisplatin + Gemcitabine + Nab-paclitaxel | Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC) (GAP Cemi) | Recruiting | USA | 0 |